Pubblicazioni

Renin-angiotensin system inhibition in cardiovascular patients at the time of COVID19. Much ado for nothing? A statement of activity from the directors of the board and the scientific Directors of the Italian Society of hypertension

2020 - HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION

Iaccarino, G.; Borghi, C.; Cicero, A. F. G.; Ferri, C.; Minuz, P.; Muiesan, M. L.; Mulatero, P.; Mule, G.; Pucci, G.; Salvetti, M.; Savoia, C.; Sechi, L. A.; Volpe, M.; Grassi, G.

Potential harmful effects of discontinuing ace-inhibitors and arbs in covid-19 patients

2020 - ELIFE

Rossi, G. P.; Sanga, V.; Barton, M.

Relationship between angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and SARS-CoV-2 infection. Where are we?

2020 - MINERVA CARDIOANGIOLOGICA

Infusino, F.; Cimino, S.; Lombardi, M.; Mancone, M.; Cavarretta, E.; Frati, G.; Pugliese, F.; Fedele, F.; Biondi Zoccai, G.

Antecedent administration of angiotensin-converting enzyme inhibitors or angiotensin ii receptor antagonists and survival after hospitalization for COVID-19 syndrome

2020 - JOURNAL OF THE AMERICAN HEART ASSOCIATION. CARDIOVASCULAR AND CEREBROVASCULAR DISEASE

Palazzuoli, A.; Mancone, M.; De Ferrari, G. M.; Forleo, G.; Secco, G. G.; Ruocco, G. M.; D'Ascenzo, F.; Monticone, S.; Paggi, A.; Vicenzi, M.; Palazzo, A. G.; Landolina, M.; Taravelli, E.; Tavazzi, G.; Blasi, F.; Infusino, F.; Fedele, F.; De Rosa, F. G.; Emmett, M.; Schussler, J. M.; Tecson, K. M.; McCullough, P. A.